does serena williams use glp 1 on Why She Chose to GLP-1 Medication Could Serena Williams' GLP-1 Disclosure

ScanXNewsGland Pharma Projects Growth Through Capacity Expansion and Product Diversification 2 min read Updated on 03 Nov 2025, 09:21 PM Reviewed by Jubin VScanX News Team AI Summary Gland Pharma plans to increase its GLP-1/cartridge production capacity from 40 million to 140 million units, a 250% expansion

Overview of glucagon-like peptide-1 and its role in glucose metabolism New-generation antidiabetic agents, particularly those targeting the glucagon-like peptide-1 (GLP-1) pathway, represent a significant advancement in the treatment of type 2 diabetes

Epub 2008 Feb 28

The secondary endpoint of 1 stage improvement in fibrosis was achieved in 34%, 36%, and 34% of subjects in the 2.4 mg, 4.8 mg, and 6 mg groups, respectively, as compared to 22% of those in the placebo group

These medications work by stimulating insulin production, lowering glucagon release, and slowing digestion together creating better glucose control and improved stability

JCI INSIGHT